Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002382248 | SCV001180027 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2018-07-24 | criteria provided, single submitter | clinical testing | The p.Y1044N variant (also known as c.3130T>A), located in coding exon 24 of the NF1 gene, results from a T to A substitution at nucleotide position 3130. The tyrosine at codon 1044 is replaced by asparagine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |